ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "rheumatic disease and viruses"

  • Abstract Number: 1319 • 2016 ACR/ARHP Annual Meeting

    Chikungunya Fever  in Patients on Biological and on Conventional Dmards  Therapy – Results from the Brazilian Register Biobadabrasil

    Aline Ranzolin1, Angela Duarte2, Claudia Marques3, Laurindo Rocha Jr4, Samia Araujo de Souza Studart5, José Caetano Macieira6, Monica Valeria Siqueira S de Vechi6, Lina Oliveira de Carvalho6, Ines Guimarães da Silveira7, Ieda Maria Magalhães Laurindo8 and BiobadaBrasil, 1Rheumatology, Instituto de Medicina Integral Professor Fernando Figueira, Recife, Brazil, 2Internal Medicine, Hospital das Clínicas - UFPE, Recife, Brazil, 3Hospital das Clínicas, Universidade Federal de Pernambuco, Recife - PE, Brazil, 4Rheumatology, Instituto de Medicina Integral Professor Fernando Figueira - IMIP, Recife, Brazil, 5Reumatologia, Hospital Geral de Fortaleza, Fortaleza, Brazil, 6Reumatologia, Hospital Federal de Sergipe, Aracaju, Brazil, 7Reumatologia, Pontificia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil, 8Internal Medicine - Rheumatology, Faculdade de Medicina da Universidade Nove de Julho, São Paulo, Brazil

      Background/Purpose:   Chikungunya fever (CHIKF) is a systemic arboviral disease manifesting with fever, acute arthritis and rash. The acute symptoms can last for days but…
  • Abstract Number: 1357 • 2015 ACR/ARHP Annual Meeting

    Cytomegalovirus (CMV) Infections in Patients with Rheumatic Diseases: Experience of a Referral Center

    Yusuf Ziya Sener1, Burak Yasin Aktas1, Abdulsamet Erden2, Levent Kilic2, Berkan Armagan2, Ahmet Cagkan Inkaya3, Omer Karadag2, Sule Apras Bilgen2 and Sedat Kiraz2, 1Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey, 2Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, 3Infection Disease, Hacettepe University Faculty of Medicine, Ankara, Turkey

    Background/Purpose: CMV is a ubiquitous herpes virus associated with significant immunosuppression. Immunosuppressive treatments and ageing is well known risk factors for CMV reactivation.  There are…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology